rosiglitazone has been researched along with Hypogonadism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Channer, KS; Jones, TH; Kapoor, D | 1 |
| Cohen, P | 1 |
1 trial(s) available for rosiglitazone and Hypogonadism
| Article | Year |
|---|---|
Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.
Topics: Adiposity; Adult; Aged; Albuminuria; Blood Pressure; Body Size; C-Reactive Protein; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Hypogonadism; Intra-Abdominal Fat; Lipids; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Treatment Outcome; Up-Regulation | 2008 |
1 other study(ies) available for rosiglitazone and Hypogonadism
| Article | Year |
|---|---|
Rosiglitazone increases testosterone in hypogonadal type 2 diabetic men.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Hypogonadism; Male; Obesity; Rosiglitazone; Testosterone; Thiazolidinediones; Vasodilator Agents | 2009 |